https://doi.org/10.4081/aiua.2021.4.501
Preliminary results of a randomized crossover clinical trial comparing a new electromagnetic and vibrating device and alpha-blocker agents in patients affected by bladder outlet obstruction secondary to benign prostatic hyperplasia
Submitted: August 27, 2021
Accepted: September 19, 2021
Published: December 22, 2021
Accepted: September 19, 2021
Abstract Views: 696
PDF: 452
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor,
Benign Prostatic Hyperplasia (BPH) is one of the main causes of patients seeking urological counselling in Western countries. It has been estimated that nearly 70 percent of United States men between the ages of 60 and 69 years, and nearly 80 percent of men ≥ 70 years, have some degree of BPH [...].
McVary KT. Epidemiology and pathophysiology of benign prostatic hyperplasia. In: UpToDate, post TW (Ed), UpToDate, Waltham, MA. 2020.
McVary KT. Lower urinary tract symptoms in men. In: UpToDate, post TW (Ed), UpToDate, Waltham, MA. 2020.
Fourcade RO, Lacoin F, Rouprêt M, et al. Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J Urol. 2012; 30:419-426.
DOI: https://doi.org/10.1007/s00345-011-0756-2
Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015; 67:1099-1109.
DOI: https://doi.org/10.1016/j.eururo.2014.12.038
Roehrborn CG, Siami P, Barkin J, et al. For the CombAT Study Group. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol. 2008; 179:616-621.
DOI: https://doi.org/10.1016/j.juro.2007.09.084
BinhiV, Savin A. Effects of weak magnetic fields on biological systems: physical aspects, Phys Us pekhi. 2003; 46:259-291.
DOI: https://doi.org/10.1070/PU2003v046n03ABEH001283
McFarlane JP, Foley SJ, de Winter P, et al. Acute suppression of idiopathic detrusor instability with magnetic stimulation of the sacral nerve roots. Br J Urol. 1997; 80:734-741.
DOI: https://doi.org/10.1046/j.1464-410X.1997.00446.x
Haddad JB, Obolensky AG, Shinnick P. The biologic effects and the therapeutic mechanism of action of electric and electromagnetic field stimulation on bone and cartilage: New findings and a review of earlier work. J Altern Complement Med. 2007; 13:485-490.
DOI: https://doi.org/10.1089/acm.2007.5270
Bosco C, Cardinale M. Nuove frontiere dell’allenamento sportivo: le vibrazioni. Effetti sul comportamento meccanico del muscolo scheletrico. Coaching and Sport Science Journal. 1998; 3:53-59.
Flieger J, Karachalios T, Khaldi L, et al. Mechanical stimulation in the form of vibration prevents postmenopausal bone loss in ovariectomized rats. Calcif Tissue Int. 1998; 63:510-514.
DOI: https://doi.org/10.1007/s002239900566
Rodrigues MP, Paiva LL, Ramos JGL, Ferla L. Vibratory perineal stimulationfor the treatment of female stress urinary incontinence: A systematic review. Int Urogynecol J. 2018; 4:555-562.
DOI: https://doi.org/10.1007/s00192-017-3444-y
Brardi S, Biandolino P, Giovannelli V, et al. Possible applications of electromagnetic fields in the treatment of symptoms related to benign prostatic hyperplasia. Am J Urol Res. 2020; 5:006-010.
ElgoharyHM, Tantawy SA. Pulsed electromagnetic field with or without exercise theraphy in the treatment of benign prostatic hyperplasia. J Phys Ther Sci. 2017; 29:1305-1310.
DOI: https://doi.org/10.1589/jpts.29.1305
Tenuta M, Tarsitano MG, Mazzotta P, et al. Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia. Andrology. 2020; 8:1076-1085.
DOI: https://doi.org/10.1111/andr.12775
Giannakopoulos XK, Giotis C, karkabounas S Ch, et al. Effects of pulsed electromagnetic fields on benign prostate hyperplasia. Int Urol Nephrol. 2011; 43:955-60.
DOI: https://doi.org/10.1007/s11255-011-9944-7
Roehrborn CG, Siami P, Barkin J, et al. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the combat study. Eur Urol. 2009; 55:461-471.
DOI: https://doi.org/10.1016/j.eururo.2008.10.037
How to Cite
Brardi, S., Romano, G., & Cevenini, G. (2021). Preliminary results of a randomized crossover clinical trial comparing a new electromagnetic and vibrating device and alpha-blocker agents in patients affected by bladder outlet obstruction secondary to benign prostatic hyperplasia. Archivio Italiano Di Urologia E Andrologia, 93(4), 501–504. https://doi.org/10.4081/aiua.2021.4.501
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.